SEC Form D private-offering filing

Bonum Therapeutics, Inc.

Name: Bonum Therapeutics, Inc. - new SEC Form D private-offering filing, Seattle, WA
Published: 2026-04-17

A new SEC Form D private-offering notice from Seattle, WA, a $32,301,381 filer-stated offering target in Biotech. The source filing is one click away.

Bonum Therapeutics, Inc. site↗ Verified via SEC Form D

Seattle biotech developing antibody controlled, targeted cytokine therapeutics for cancer.

Filed 2026-04-17Filed to raise $32,301,381First money in 2026-04-03Raised so far $26,907,396HQ (as filed) Seattle, WASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified bonumtx.com↗Named in the filing 11 executives & directors

Open this row on the live feed →More new filings in Washington →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.